mecasermin
Selected indexed studies
- Mecasermin for primary insulin-like growth factor-1 deficiency. (Aust Prescr, 2022) [PMID:36479333]
- Mecasermin. (BioDrugs, 2008) [PMID:18481900]
- Mecasermin rinfabate. (Drugs Today (Barc), 2007) [PMID:17380212]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Mecasermin for primary insulin-like growth factor-1 deficiency. (2022) pubmed
- Mecasermin. (2008) pubmed
- Mecasermin rinfabate. (2007) pubmed
- Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX. (2008) pubmed
- PMID:37906659 (2022) pubmed
- Mecasermin Tercica. (2006) pubmed
- Mecasermin for the treatment of Rett Syndrome: a systematic review. (2025) pubmed
- PMID:37797116 (2022) pubmed
- Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3. (2005) pubmed
- Mecasermin (recombinant human insulin-like growth factor I). (2009) pubmed